A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease

James C. Burnett, Dejan Opsenica, Kamaraj Sriraghavan, Rekha G. Panchal, Gordon Ruthel, Ann R. Hermone, Tam L. Nguyen, Tara A. Kenny, Douglas J. Lane, Connor F. McGrath, James J. Schmidt, Jonathan L. Vennerstrom, Rick Gussio, Bogdan A. Šolaja, Sina Bavari

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

We previously identified structurally diverse small molecule (non-peptidic) inhibitors (SMNPIs) of the botulinum neurotoxin serotype A (BoNT/A) light chain (LC). Of these, several (including antimalarial drugs) contained a 4-amino-7-chloroquinoline (ACQ) substructure and a separate positive ionizable amine component. The same antimalarials have also been found to interfere with BoNT/A translocation into neurons, via pH elevation of the toxin-mediated endosome. Thus, this structural class of small molecules may serve as dual-function BoNT/A inhibitors. In this study, we used a refined pharmacophore for BoNT/A LC inhibition to identify four new, potent inhibitors of this structural class (IC50's ranged from 3.2 to 17 μM). Molecular docking indicated that the binding modes for the new SMNPIs are consistent with those of other inhibitors that we have identified, further supporting our structure-based pharmacophore. Finally, structural motifs of the new SMNPIs, as well as two structure-based derivatives, were examined for activity, providing valuable information about pharmacophore component contributions to inhibition.

Original languageEnglish (US)
Pages (from-to)2127-2136
Number of pages10
JournalJournal of Medicinal Chemistry
Volume50
Issue number9
DOIs
StatePublished - May 3 2007

Fingerprint

Neurotoxins
Metalloproteases
Molecules
Antimalarials
Light
Endosomes
Inhibitory Concentration 50
Neurons
Amines
Derivatives
Serogroup

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Burnett, J. C., Opsenica, D., Sriraghavan, K., Panchal, R. G., Ruthel, G., Hermone, A. R., ... Bavari, S. (2007). A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease. Journal of Medicinal Chemistry, 50(9), 2127-2136. https://doi.org/10.1021/jm061446e

A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease. / Burnett, James C.; Opsenica, Dejan; Sriraghavan, Kamaraj; Panchal, Rekha G.; Ruthel, Gordon; Hermone, Ann R.; Nguyen, Tam L.; Kenny, Tara A.; Lane, Douglas J.; McGrath, Connor F.; Schmidt, James J.; Vennerstrom, Jonathan L.; Gussio, Rick; Šolaja, Bogdan A.; Bavari, Sina.

In: Journal of Medicinal Chemistry, Vol. 50, No. 9, 03.05.2007, p. 2127-2136.

Research output: Contribution to journalArticle

Burnett, JC, Opsenica, D, Sriraghavan, K, Panchal, RG, Ruthel, G, Hermone, AR, Nguyen, TL, Kenny, TA, Lane, DJ, McGrath, CF, Schmidt, JJ, Vennerstrom, JL, Gussio, R, Šolaja, BA & Bavari, S 2007, 'A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease', Journal of Medicinal Chemistry, vol. 50, no. 9, pp. 2127-2136. https://doi.org/10.1021/jm061446e
Burnett, James C. ; Opsenica, Dejan ; Sriraghavan, Kamaraj ; Panchal, Rekha G. ; Ruthel, Gordon ; Hermone, Ann R. ; Nguyen, Tam L. ; Kenny, Tara A. ; Lane, Douglas J. ; McGrath, Connor F. ; Schmidt, James J. ; Vennerstrom, Jonathan L. ; Gussio, Rick ; Šolaja, Bogdan A. ; Bavari, Sina. / A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease. In: Journal of Medicinal Chemistry. 2007 ; Vol. 50, No. 9. pp. 2127-2136.
@article{facfa917741a405f9367e885ba0f02e4,
title = "A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease",
abstract = "We previously identified structurally diverse small molecule (non-peptidic) inhibitors (SMNPIs) of the botulinum neurotoxin serotype A (BoNT/A) light chain (LC). Of these, several (including antimalarial drugs) contained a 4-amino-7-chloroquinoline (ACQ) substructure and a separate positive ionizable amine component. The same antimalarials have also been found to interfere with BoNT/A translocation into neurons, via pH elevation of the toxin-mediated endosome. Thus, this structural class of small molecules may serve as dual-function BoNT/A inhibitors. In this study, we used a refined pharmacophore for BoNT/A LC inhibition to identify four new, potent inhibitors of this structural class (IC50's ranged from 3.2 to 17 μM). Molecular docking indicated that the binding modes for the new SMNPIs are consistent with those of other inhibitors that we have identified, further supporting our structure-based pharmacophore. Finally, structural motifs of the new SMNPIs, as well as two structure-based derivatives, were examined for activity, providing valuable information about pharmacophore component contributions to inhibition.",
author = "Burnett, {James C.} and Dejan Opsenica and Kamaraj Sriraghavan and Panchal, {Rekha G.} and Gordon Ruthel and Hermone, {Ann R.} and Nguyen, {Tam L.} and Kenny, {Tara A.} and Lane, {Douglas J.} and McGrath, {Connor F.} and Schmidt, {James J.} and Vennerstrom, {Jonathan L.} and Rick Gussio and Šolaja, {Bogdan A.} and Sina Bavari",
year = "2007",
month = "5",
day = "3",
doi = "10.1021/jm061446e",
language = "English (US)",
volume = "50",
pages = "2127--2136",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "9",

}

TY - JOUR

T1 - A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease

AU - Burnett, James C.

AU - Opsenica, Dejan

AU - Sriraghavan, Kamaraj

AU - Panchal, Rekha G.

AU - Ruthel, Gordon

AU - Hermone, Ann R.

AU - Nguyen, Tam L.

AU - Kenny, Tara A.

AU - Lane, Douglas J.

AU - McGrath, Connor F.

AU - Schmidt, James J.

AU - Vennerstrom, Jonathan L.

AU - Gussio, Rick

AU - Šolaja, Bogdan A.

AU - Bavari, Sina

PY - 2007/5/3

Y1 - 2007/5/3

N2 - We previously identified structurally diverse small molecule (non-peptidic) inhibitors (SMNPIs) of the botulinum neurotoxin serotype A (BoNT/A) light chain (LC). Of these, several (including antimalarial drugs) contained a 4-amino-7-chloroquinoline (ACQ) substructure and a separate positive ionizable amine component. The same antimalarials have also been found to interfere with BoNT/A translocation into neurons, via pH elevation of the toxin-mediated endosome. Thus, this structural class of small molecules may serve as dual-function BoNT/A inhibitors. In this study, we used a refined pharmacophore for BoNT/A LC inhibition to identify four new, potent inhibitors of this structural class (IC50's ranged from 3.2 to 17 μM). Molecular docking indicated that the binding modes for the new SMNPIs are consistent with those of other inhibitors that we have identified, further supporting our structure-based pharmacophore. Finally, structural motifs of the new SMNPIs, as well as two structure-based derivatives, were examined for activity, providing valuable information about pharmacophore component contributions to inhibition.

AB - We previously identified structurally diverse small molecule (non-peptidic) inhibitors (SMNPIs) of the botulinum neurotoxin serotype A (BoNT/A) light chain (LC). Of these, several (including antimalarial drugs) contained a 4-amino-7-chloroquinoline (ACQ) substructure and a separate positive ionizable amine component. The same antimalarials have also been found to interfere with BoNT/A translocation into neurons, via pH elevation of the toxin-mediated endosome. Thus, this structural class of small molecules may serve as dual-function BoNT/A inhibitors. In this study, we used a refined pharmacophore for BoNT/A LC inhibition to identify four new, potent inhibitors of this structural class (IC50's ranged from 3.2 to 17 μM). Molecular docking indicated that the binding modes for the new SMNPIs are consistent with those of other inhibitors that we have identified, further supporting our structure-based pharmacophore. Finally, structural motifs of the new SMNPIs, as well as two structure-based derivatives, were examined for activity, providing valuable information about pharmacophore component contributions to inhibition.

UR - http://www.scopus.com/inward/record.url?scp=34247633446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247633446&partnerID=8YFLogxK

U2 - 10.1021/jm061446e

DO - 10.1021/jm061446e

M3 - Article

C2 - 17417831

AN - SCOPUS:34247633446

VL - 50

SP - 2127

EP - 2136

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 9

ER -